Sema4, Stamford, Conn, is now performing molecular testing for the detection of SARS-CoV-2, the coronavirus responsible for covid-19. The company is working in partnership with the state of Connecticut and regional healthcare providers to address the pressing need for high-throughput testing, including regular screening of medical personnel and other high-risk populations. Doctors in Connecticut and New York are able to order the test. Sema4 is processing samples in its clinical laboratory, which can analyze 6,000 covid-19 tests per week and return results within 24 to 48 hours.
“During this difficult time, the Sema4 team is eager to join the fight to combat covid-19 and to help people across Connecticut and New York,” says Eric Schadt, PhD, founder and chief executive officer of Sema4. “After delivering accurate testing results to hundreds of thousands of patients every year, we are ready to apply our clinical expertise and substantial laboratory resources to the covid-19 crisis, giving much-needed information quickly to our provider partners and their patients.”
The covid-19 tests performed by Sema4 have been validated in accordance with FDA’s emergency use authorization and are processed in the company’s CLIA-licensed and CAP-compliant laboratory. Samples are collected by a healthcare provider via nasal or oral swab, and testing is offered with no out-of-pocket cost to insured patients. The state of Connecticut will cover testing costs for uninsured residents.
For more information, visit Sema4.